Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies

James M. Bogenberger; Devora Delman; Nanna Hansen; Riccardo Valdez; Veena Fauble; Ruben A. Mesa; Raoul Tibes

doi:10.3109/10428194.2014.910657

Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies

James M. Bogenberger, Devora Delman, Nanna Hansen, Riccardo Valdez, Veena Fauble, Ruben A. Mesa, Raoul Tibes

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	226-229
Number of pages	4
Journal	Leukemia and Lymphoma
Volume	56
Issue number	1
DOIs	https://doi.org/10.3109/10428194.2014.910657
State	Published - Jan 1 2015

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.3109/10428194.2014.910657

Cite this

@article{467524e2cb3b4529a0e72f923b9f7dc8,

title = "Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies",

author = "Bogenberger, {James M.} and Devora Delman and Nanna Hansen and Riccardo Valdez and Veena Fauble and Mesa, {Ruben A.} and Raoul Tibes",

year = "2015",

month = jan,

day = "1",

doi = "10.3109/10428194.2014.910657",

language = "English (US)",

volume = "56",

pages = "226--229",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "1",

}

TY - JOUR

T1 - Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies

AU - Bogenberger, James M.

AU - Delman, Devora

AU - Hansen, Nanna

AU - Valdez, Riccardo

AU - Fauble, Veena

AU - Mesa, Ruben A.

AU - Tibes, Raoul

PY - 2015/1/1

Y1 - 2015/1/1

UR - http://www.scopus.com/inward/record.url?scp=84922360342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922360342&partnerID=8YFLogxK

U2 - 10.3109/10428194.2014.910657

DO - 10.3109/10428194.2014.910657

M3 - Letter

C2 - 24707940

AN - SCOPUS:84922360342

SN - 1042-8194

VL - 56

SP - 226

EP - 229

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 1

ER -

Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this